Pediatric antiphospholipid antibodies and antiphospholipid syndrome

Seminars in Thrombosis and Hemostasis
Beverley J Hunt

Abstract

Antiphospholipid syndrome (APS) can occur in children, like adults, with the same diverse spectrum of thrombotic sites but predominately with deep vein thrombosis and stroke. In contrast with adults, however, transient nonthrombogenic antiphospholipid (aPL) antibodies are seen more commonly, usually after childhood infections. In those with "true" aPL antibodies, recurrent thrombotic events seem less frequent than in adults, perhaps reflecting the less prothrombotic hemostatic state of childhood. Children with thrombotic events in APS present difficult management problems, as there is little evidence-based medicine. The duration and intensity of anticoagulation are unresolved management issues, but a target international normalized ratio of 2 to 3 is used by most. Multicenter randomized controlled trials would provide answers to some of these issues but are difficult to organize due to ethical issues and the rarity of the condition. A pediatric APS registry such as the Ped-APS Register is more easy to organize and can yield informative data.

Citations

Dec 18, 2008·Clinical Reviews in Allergy & Immunology·Mario García-CarrascoRicard Cervera
Jul 1, 1997·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·J T Lie
Jan 30, 2010·Critical Care Medicine·Robert I Parker
Apr 7, 2011·Current Opinion in Pediatrics·Andrew I Shulman, Marilynn Punaro
Nov 11, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Alenka Trampus-Bakija
Feb 1, 2011·Clinical Chemistry and Laboratory Medicine : CCLM·Emmanuel J Favaloro, Richard C W Wong
Dec 9, 2009·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·Alejandro Gru, Louis P Dehner
Mar 4, 2014·Archives of Disease in Childhood·A MidgleyM W Beresford
Aug 7, 2009·British Journal of Haematology·Leslie Raffini, Courtney Thornburg
Dec 9, 2008·Pediatric Blood & Cancer·Amulya A Nageswara RaoVilmarie Rodriguez
Mar 3, 2010·European Journal of Clinical Investigation·Carlos E M RodriguesYehuda Shoenfeld
Sep 25, 2015·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Catherine QuinlanKjell Tullus
Dec 8, 2015·Hematology·Shruti Chaturvedi, Keith R McCrae
Sep 13, 2016·Expert Review of Hematology·Pier Luigi MeroniIrene Pontikaki
May 22, 2013·Lupus·D M WaheziUNKNOWN Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators
Feb 18, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Lakshmi Srivaths, Jennifer E Dietrich
Dec 17, 2011·The Journal of Rheumatology·Dawn M WaheziJacob H Rand
Jul 28, 2019·Current Opinion in Hematology·Cristina Tarango, Joseph S Palumbo
Mar 19, 2020·Current Opinion in Rheumatology·Jacqueline A MadisonJason S Knight
Jul 29, 2010·Expert Review of Neurotherapeutics·Lonneke Ml de LauDiederik Wj Dippel
May 1, 2010·Auto- Immunity Highlights·Emmanuel J Favaloro, Richard C W Wong
Dec 14, 2018·Frontiers in Pediatrics·Chris Wincup, Yiannis Ioannou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.